Leaderboard

En | De
No articles selected!     View Cart  
You are here: Oncology » Gynecologic Neoplasms 15. August 2026
Search
medline.ch
Gynecologic Neoplasms
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
Musculoskeletal System
Blood
Endocrine System
Gynecologic Neoplasms
Skin
Gastrointestinal
ORL
Respiratory Tract
Urologic Neoplasms
CNS
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 16687  Previews Next
   
   Articles 1 - 20 / 333722  
   
Methodological Concerns Regarding the Partially Randomized Design and Statistical Inference in Preoperative TEAS for Breast Cancer Patients: A Letter to the Editor [Letter].
J Pain Res
Wei M.
PMID: 42602658 [PubMed]


Fertility-Sparing Management in Ovarian Cancer: A Systematic Review.
Int J Womens Health
Fitriyanto IA, Salima S, Iswanti W, Azizah JN.
PMID: 42602654 [PubMed]


In silico and In vitro studies of EGFR kinase and Anilide derivatives as inhibitors against Breast Cancer.
Biotechnol Notes
Parab MM, Gupta PP, Shetty S, Chhajed SS, Shukla G, Bapat K, Dasgupta D, Boruah P.
PMID: 42602599 [PubMed]


A narrative review of in vitro studies on the role of reactive oxygen species in aggravating high-grade serous ovarian cancer development.
Front Oncol
Lee J, Yeo SG, Kim HO, Lee JM, Singh MK, Kim SS, Oh TI, Park DC.
PMID: 42602565 [PubMed]


Multimodal AI in high-grade serous ovarian cancer: integrated prediction and clinical decision-making.
Front Oncol
Pelissier-Combescure M, Villemin JP, Bonzom D, Berger C, Estoup-Streiff C, Lakhman Y, Woitek R, Colombo PE, Lin Z, Li H, Nougaret S.
PMID: 42602542 [PubMed]


Impact of supportive bra use and surgical factors on seroma and pain following breast-conserving surgery: a single-center retrospective study.
J Med Life
Bölük SE, Bölük S, Bilgiç Ç, Ako.
PMID: 42602434 [PubMed - indexed for MEDLINE]


Rationale and trial design of RIBOLARIS: A phase II trial of neoadjuvant and adjuvant ribociclib plus endocrine therapy for clinically high-risk HR+/HER2-negative breast cancer.
Ther Adv Med Oncol
Cottu P, Pascual T, Lemonnier J, Hu H, Roux E, Connolly RM, Ma CX, Wolff AC, Crestani T, Tolosa P, Ferrero-Cafiero JM, Mulero-Sánchez A, Salvador F, Villacampa G, Gavilá J, de La Motte Rouge T, Prat A.
PMID: 42602220 [PubMed]


Dynamic circulating tumor DNA profiling of ESR1 mutations in HR+/HER2- advanced breast cancer: from prognostic biomarker to clinical decision-making - a comprehensive review.
Front Oncol
Ren S, Li P, Zhu D, Zhao L, Zhang X.
PMID: 42601904 [PubMed]


Longitudinal monitoring of circulating tumor cell phenotypic conversion as a predictor of late recurrence in breast cancer: a prospective feasibility study using the GenoCTC platform.
Front Oncol
Chelakkot C, Chelakkot VS, Shin H, Cho C, Park J, Choi J, Hong D, Lee HS, Shin YK.
PMID: 42601892 [PubMed]


Correlation study between inflammatory, nutritional and metabolic indicators and the risk of invasive ductal carcinoma of the breast.
Front Oncol
Chen P, Lv X, Su H, Wu H, Zhang Z, Zhang B, Zhang F.
PMID: 42601855 [PubMed]


Prognostic significance of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy: A retrospective cohort study.
Medicine (Baltimore)
Aliyev A, Adilli A, Ismayilsoy A, Aghayarli F, Babazade I, Ibrahimli A, Isayev C, Karn T, Gasimli B, Gasimli K.
PMID: 42601757 [PubMed - indexed for MEDLINE]


Factors influencing acupuncture regimen completion by breast cancer patients: real-world data from an NCI-designated comprehensive cancer center.
Support Care Cancer
Zelaya MG, Borjigin M, Lahiji R, Fung G, Bausum A, Melikian M, Catic A, Mumford S, Slomik H, Nguyen J, Patil D, Suk R, Smith-Graziani D, Kalinsky K, Master VA.
PMID: 42601524 [PubMed - indexed for MEDLINE]


Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL-6 and Insulin in Patients With Polycystic Ovary Syndrome.
J Obstet Gynaecol Res
Jamshidian S, Jalilvand F.
PMID: 42601227 [PubMed - indexed for MEDLINE]


Congenital adrenal hyperplasia, ovarian adrenal rest tumours and Addison's disease: an exceptional clinical constellation.
BMJ Case Rep
Emara Y, Leibnitz S, Lauber-Biason A, Auchus RJ, Berger CT, Ntoulias N, Cavelti-Weder C, Winzeler B.
PMID: 42601080 [PubMed - indexed for MEDLINE]


The Biphasic Role of Reactive Oxygen Species in Ovarian Cancer Progression and Therapeutics: Crosstalk Among Metabolism, Ferroptosis, and the Tumor Immune Microenvironment.
Crit Rev Oncol Hematol
Hou Y, Jiang Y, Li H, Jiang M, Han Y, Zhang Y.
PMID: 42600958 [PubMed - as supplied by publisher]


Geographic Disparities, Trial Characteristics, and Transparency of 3,720 Ovarian Cancer Clinical Trials.
J Cancer Policy
Yin X, Cobos JM, Chen H.
PMID: 42600890 [PubMed - as supplied by publisher]


Acute radiation side effects of proton versus photon therapy following surgery for early breast cancer, a sub-study of the randomised controlled DBCG Proton Trial.
Int J Radiat Oncol Biol Phys
Hřgsbjerg KW, Petersen SE, Maae E, Matthiessen LW, Mřller M, Maraldo MV, Mogensen MB, Nielsen MH, Kronborg CJS, Offersen BV.
PMID: 42600707 [PubMed - as supplied by publisher]


TEMPORAL DYNAMICS OF GLOBAL LONGITUDINAL STRAIN AND NT-PROBNP IN THE EARLY DETECTION OF ANTHRACYCLINE-INDUCED CARDIOTOXICITY: A 24-MONTH PROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH BREAST CANCER.
Georgian Med News
Chitadze T.
PMID: 42600597 [PubMed - indexed for MEDLINE]


Prognostic Impact of Combined Oral Contraceptive Use Among Ovarian Cancer Patients in Addis Ababa, Ethiopia: A Cohort Study.
Cancer Control
Habteyes AT, Mekonen FT, Haile TA.
PMID: 42600139 [PubMed - indexed for MEDLINE]


Feasibility of an Online Shared Reading Intervention in Survivors of Gynecological Cancer: Protocol for a Multiple-Baseline Single-Case Study.
JMIR Res Protoc
Tomescu-Stachie S, Kirby S, Merwood A, Sivyer K, Al-Abbadey M.
PMID: 42600072 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 333722    Page 1 of 16687  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1